Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
American Journal of Obstetrics and Gynecology|August 6, 2004
Diagnoses and outcomes in cervical cancer screening: a population-based studyRalph P Insinga, Andrew G Glass, Brenda B RushCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 10, 2004
Pap screening in a U.S. health planRalph P Insinga, Andrew G Glass, Brenda B RushAmerican Journal of Obstetrics and Gynecology|August 6, 2004
The health care costs of cervical human papillomavirus--related diseaseRalph P Insinga, Andrew G Glass, Brenda B RushMedical Decision Making : an International Journal of the Society for Medical Decision Making|June 23, 2007
Abnormal outcomes following cervical cancer screening: event duration and health utility lossRalph P Insinga, Andrew G Glass, Evan R Myers, et al.The Journal of Infectious Diseases|November 17, 2006
Human papillomavirus prevalence in women who have and have not undergone hysterectomiesPhilip E Castle, Mark Schiffman, Andrew G Glass, et al.Cancer|November 2, 2002
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative womenPhilip E Castle, Sholom Wacholder, Mark E Sherman, et al.Journal of the National Cancer Institute|July 21, 2005
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practiceMichelle J Khan, Philip E Castle, Attila T Lorincz, et al.Mutation Research|June 23, 2007
Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry studyM Margaret Pratt, Paul Sirajuddin, Miriam C Poirier, et al.Journal of the National Cancer Institute|September 19, 2002
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected womenPhilip E Castle, Sholom Wacholder, Attila T Lorincz, et al.Journal of the National Cancer Institute|January 2, 2003
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysisMark E Sherman, Attila T Lorincz, David R Scott, et al.Pageof 3